Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;25(5):1230-8.
doi: 10.1007/s11095-007-9526-7. Epub 2008 Jan 9.

Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA

Affiliations

Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA

Hyun Joon Kong et al. Pharm Res. 2008 May.

Abstract

Purpose: To attain the effective local and sustained delivery of plasmid DNA (pDNA) encoding for a growth factor.

Methods: We hypothesized that controlling the degradation rate of biomaterials encapsulating pDNA via concurrent physical dissociation of the cross-linked structure and hydrolytic chain breakage of polymers would allow one to significantly broaden the range of pDNA release rate. This hypothesis was examined using ionically cross-linked polysaccharide hydrogels which were previously designed to rapidly degrade via engineering of ionic cross-linking junction and partial oxidation of polysaccharide chains.

Results: The hydrogel degradation rates were varied over the broad range, and pDNA release correlated with the gel degradation rate. Degradable hydrogels were used for the local and sustained delivery of a pDNA encoding for vascular endothelial growth factor (VEGF) in the ischemic hindlimbs of mice, and local pDNA release significantly improved the recovery of blood perfusion as compared with a bolus injection of VEGFencoding pDNA.

Conclusion: This strategy to control the hydrogel degradation rate may be useful in regulating the delivery of a broad array of macromolecular drugs, and subsequently improve their therapeutic efficacy.

PubMed Disclaimer

References

    1. J Control Release. 2005 Jun 2;104(3):521-39 - PubMed
    1. J Pharm Sci. 1998 Jun;87(6):678-83 - PubMed
    1. Tissue Eng. 2005 Mar-Apr;11(3-4):546-55 - PubMed
    1. Biophys J. 2003 Nov;85(5):3106-19 - PubMed
    1. J Thromb Haemost. 2007 Mar;5(3):590-8 - PubMed

Publication types

LinkOut - more resources